Insider Ledger
BioAge Labs, Inc. (BIOA) insider buying and SEC filings
BioAge Labs, Inc. · CIK 1709941
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$7.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 29–30, 2026 | Planned (10b5-1) | Shane Barton (Principal Accounting Officer) sold 62,566 shares between Jun 29 and Jun 30 at about $25.20 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 1, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 8,820 shares at $17.81 ($157K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 7,433 shares at $20.30 ($151K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 7,433 shares at $18.75 ($139K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 3, 2026 |
| Jan 13, 2026 | Planned (10b5-1) | Kristen Fortney (CEO and Director) sold 233,107 shares at about $18.12 ($4.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 976,949 shares. | SEC filing Filed Jan 15, 2026 |
| Jan 13, 2026 | Planned (10b5-1) | Dov A. Md Goldstein (CFO) sold 27,000 shares at about $19.70 ($532K), marked as a 10b5-1 plan trade. Holdings down 55% to 22,408 shares. | SEC filing Filed Jan 15, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 7,433 shares at about $12.85 ($96K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 9, 2025 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 18,000 shares at $12.00 ($216K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 11, 2025 |
| Dec 4, 2025 | Planned (10b5-1) | Paul D. Rubin (Chief Medical Officer) sold 68,897 shares at about $10.19 ($702K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 5, 2025 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BIOA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.